Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
04/2003
04/03/2003WO2003002531A3 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
04/03/2003WO2003002530A3 Pyrrolidines as dipeptidyl peptidase inhibitors
04/03/2003WO2002102766A3 Combretastatin a-3 prodrug
04/03/2003WO2002100418B1 Exothermic formulations for the treatment of ectoparasites
04/03/2003WO2002100152A3 Solution-phase combinatiorial library synthesis and pharmaceutically active compounds produced thereby
04/03/2003WO2002092016A3 Therapeutic use of rank antagonists
04/03/2003WO2002088336A3 Genetically modified yt cell line and use thereof
04/03/2003WO2002086078A3 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
04/03/2003WO2002070559A3 Nuclear hormone receptor ligand binding domains
04/03/2003WO2002059256A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
04/03/2003WO2002042444A8 Fungal gene cluster associated with pathogenesis
04/03/2003WO2002032414A3 Ribavirin-pegylated interferon alfa hcv combination therapy
04/03/2003WO2002014369A9 Human kininogen d5 domain polypeptides and their use
04/03/2003WO2002013846A3 Antifungal combination therapy
04/03/2003WO2002000860A3 Novel proteases
04/03/2003WO2001072782A9 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
04/03/2003US20030065175 Novel heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them
04/03/2003US20030065174 Antiinflammatory agents; analgesics
04/03/2003US20030065027 Compositions for controlling microorganisms, comprising primary and secondary esters of polyglycerol in an effective ratio
04/03/2003US20030065023 Anticancer agents, viricides, psychological disorders
04/03/2003US20030065006 Viricides; anticancer agents
04/03/2003US20030065005 Heterocyclic ether substituted imidazoquinolines
04/03/2003US20030064991 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
04/03/2003US20030064987 Immunology moderators; interleukin antagonist; anticancer agents
04/03/2003US20030064986 Method for preparing pyrimidone derivatives with antifungal activity
04/03/2003US20030064971 Fusidic acid derivatives
04/03/2003US20030064968 Viricides, anticarcinogneic agents
04/03/2003US20030064952 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis
04/03/2003US20030064943 High affinity TGFbeta nucleic acid ligands and inhibitors
04/03/2003US20030064939 Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
04/03/2003US20030064927 Regeneration of soft tissue; wound healing agents
04/03/2003US20030064919 Novel polypeptides and polynucleotides encoding same
04/03/2003US20030064503 Device
04/03/2003US20030064430 Novel steroid-activated nuclear receptors and uses therefor
04/03/2003US20030064369 Novel proteins and nucleic acids encoding same
04/03/2003US20030064361 Preparing viral vaccine; obtain glycoprotein, determine neutralizing epitope, generate vaccine associated with neutralizing epitope
04/03/2003US20030064114 For vasodilatation and inhibition of transplant rejection
04/03/2003US20030064102 Antimicrobial Composition
04/03/2003US20030064098 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
04/03/2003US20030064097 For delivery of drugs, nutrionals, cosmeceuticals and diagnostic agents
04/03/2003US20030064095 Microfabricated nanopore device for sustained release of therapeutic agent
04/03/2003US20030064079 Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle
04/03/2003US20030064078 Vaccines
04/03/2003US20030064074 Recombinant gelatins in vaccines
04/03/2003US20030064073 Active immunization using a siderophore receptor protein
04/03/2003US20030064071 Method of using a facilitator of retroviral entry into cells
04/03/2003US20030064052 Useful for maintaining controlled and reliable dosage of the therapeutic agent via pulmonary delivery
04/03/2003US20030064036 Coating and binding agent for pharmaceutical formulations with improved storage stability
04/03/2003CA2461903A1 Monobactam antibacterial compounds and methods of use thereof
04/03/2003CA2461853A1 Anti-fusion assay
04/03/2003CA2461806A1 Water-soluble phenylpyridazine derivatives and medicines containing the same
04/03/2003CA2461801A1 Sphingolipids
04/03/2003CA2461710A1 Incapacitated whole-cell immunogenic bacterial compositions
04/03/2003CA2461705A1 Coadministration of transport protein with conjugated cobalamin to deliver agents
04/03/2003CA2461666A1 Combination therapies for immune mediated diseases
04/03/2003CA2461526A1 Aptamers containing sequences of nucleic acids or nucleic acid analogues bound homologously, or in novel complexes
04/03/2003CA2461363A1 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
04/03/2003CA2461360A1 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors
04/03/2003CA2461305A1 Methods of suppressing microglial activation and systemic inflammatory responses
04/03/2003CA2461140A1 Inactivation of papillomavirus
04/03/2003CA2461095A1 Process for making substituted pyrazoles
04/03/2003CA2461091A1 Use of hmgb1 for the activation of dendritic cells
04/03/2003CA2460953A1 Proteins associated with cell growth, differentiation, and death
04/03/2003CA2459943A1 Androstanes as androgen receptor modulators
04/03/2003CA2453985A1 Receptors and membrane-associated proteins
04/03/2003CA2446904A1 Delivery of drug esters through an inhalation route
04/03/2003CA2443410A1 Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof
04/02/2003EP1298348A1 Bush, group of bush, suspension cross-member, vehicle, method for mounting a bush and method for mounting a group of bushes
04/02/2003EP1298215A2 Recombinant production of immunologically reactive truncated CMV glycoprotein H
04/02/2003EP1298211A2 Polynucleotide segment of HPV16 Genome
04/02/2003EP1298208A2 Ribozymes targeting a hiv tat sequence
04/02/2003EP1298139A2 Avian herpes virus-based recombinant infectious bursal disease vaccine
04/02/2003EP1298137A1 Novel substance having physiological activity, process for producing the same, and use
04/02/2003EP1298131A1 Quinolonecarboxylic acid derivative
04/02/2003EP1297845A2 Toxoid of dermonecrotic toxin produced by bordetella
04/02/2003EP1297844A2 Multicomponent meningococcal vaccine
04/02/2003EP1297834A1 Inhibitor for enzyme having two divalent metal ions as active centers
04/02/2003EP1297180A2 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
04/02/2003EP1297152A2 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof
04/02/2003EP1297147A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
04/02/2003EP1297145A2 Streptococcus pyogenes antigen
04/02/2003EP1297137A2 Gp286 nucleic acids and polypeptides
04/02/2003EP1297135A2 Pd-l2 molecules: novel pd-1 ligands and uses therefor
04/02/2003EP1297130A2 G-protein coupled receptors
04/02/2003EP1297129A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use
04/02/2003EP1297126A1 Nucleotide and amino acid sequences of a cellular inhibitor of the dna replication in the epstein-barr herpes virus
04/02/2003EP1297017A2 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
04/02/2003EP1297014A2 Transporters and ion channels
04/02/2003EP1297011A1 The t-cell protein tzon7, peptides and antibodies derived therefrom and uses thereof
04/02/2003EP1297005A2 Immunisation against chlamydia pneumoniae
04/02/2003EP1297001A1 Amphipathic linear peptides and compositions containing same
04/02/2003EP1296998A2 Hcv variants
04/02/2003EP1296997A1 Base analogues
04/02/2003EP1296996A1 Purine derivatives
04/02/2003EP1296995A2 3'-prodrugs of 2'-deoxy-beta-l-nucleosides
04/02/2003EP1296989A2 Polycyclic xanthones as antibiotics
04/02/2003EP1296978A2 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity
04/02/2003EP1296976A1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them
04/02/2003EP1296972A1 Arylmethylamine derivatives for use as tryptase inhibitors
04/02/2003EP1296951A1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3']bipyridinyl in pure crystalline form and process for synthesis
1 ... 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 ... 1798